Home » Business » Medical & Pharmaceuticals » Archive for the ‘Pharmeceuticals’ Category

Pharmeceuticals Press Releases

Sort by:

Dr. Reddy’s revenues cross $2 billion milestone in FY12

May 12, 2012 | Author: | Posted in Pharmeceuticals

Mumbai, India, May 11th, 2012: Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its audited consolidated financial results for the quarter and full year ended March 31, 2012 under International Financial Reporting Standards (IFRS). Key Highlights oConsolidated revenues at `96.7 billion in FY12, year-on-year growth of 30%, driven by key markets of North America and …

Click here to read full Press Release
Tags:

Dr. Reddy’s announces the launch of Quetiapine Fumarate Tablets

March 28, 2012 | Author: | Posted in Pharmeceuticals

  Hyderabad, India, March 28, 2012   Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Quetiapine fumarate tablets (25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg), a bioequivalent generic version of SEROQUEL® tablets in the US market on March 27, 2012 following the approval by the United …

Click here to read full Press Release

NEW DIRECTOR TAKES CHARGE OF BUSINESS SUPPORT ACTIVITY AT COLOPLAST IN PETERBOROUGH

January 25, 2012 | Author: | Posted in Pharmeceuticals

Allan Kjer has been appointed as business support director at Peterborough-based medical devices company Coloplast.   It is Danish-born Allan’s fourth job with the company. After working in finance jobs for Nordea Bank and Thomas Cook in Copenhagen he joined Coloplast as treasurer in 2006. His subsequent career with the company has seen him working …

Click here to read full Press Release

A Social Media Strategy in Times Square Boasts Great Results for TheraMax Cold and Flu

January 9, 2012 | Author: | Posted in Pharmeceuticals

January 5, 2012   Contact: Megale Public Relations at (347) 92-STARS or (347) 927-8277 E Mail: info@mediaproductions.tv   A Social Media Strategy in Times Square Boasts Great Results for TheraMax Cold and Flu (New York, NY) – TheraBiogen Inc. (TRAB:OTCBB), creator of TheraMaxtm Cold and Flu utilized the busy holiday season underneath their billboard in …

Click here to read full Press Release

Better Control, Healthier Yields: Biotech Process Analytical Technology

October 27, 2011 | Author: | Posted in Pharmeceuticals

  METTLER TOLEDO recently published a white paper entitled "Process Analytical Technology (PAT) for Biotech: A Review of Recently Reported Applications in Fermentation and Bioprocessing." The paper explores how Process Analytical Technologies, or PATs, help optimize fermentation and bioprocess actions critical to pharmaceutical, specialty chemical, commodity chemical, and bulk fuel development and manufacturing.   "PAT …

Click here to read full Press Release

EPM magazine appoints ELC GROUP as regular contributor

September 27, 2011 | Author: | Posted in Pharmeceuticals

September 27th 2011 – ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, announced today that it would be working with the editorial team of European Pharmaceutical Manufacturer magazine to supply expert opinion on the regulatory affairs industry. ELC GROUP’s Advisory Board member, Dr. Paolo Biffignandi MD, PhD, QPPV, FTOPRA, will write the regular column. Dr. …

Click here to read full Press Release

Unique Tonometer DIATON Presented at Optometry’s Meeting AOA/AOSA to 1000’s of Optometrists. Non-corneal DIATON Tonometry Revolutionizes Glaucoma Testing.

July 1, 2011 | Author: | Posted in Pharmeceuticals

The only non-corneal and non-contact  Tonometer DIATON now enables optometrists and other healthcare professionals who provide primary vision care to test intraocular pressure (IOP) for glaucoma Through the EYELID. Quick and painless, handheld Diaton pen-like tonometer readings are not affected by contact lenses or other corneal properties. BiCOM Inc., home of tonometer Diaton is proud …

Click here to read full Press Release

Preparing a Paediatric Investigation Plan

June 7, 2011 | Author: | Posted in Pharmeceuticals

The European Commission proposed the implementation of Paediatric Investigation Plans (PIPs) to help ensure that treatments for children are included in the mainstream drug development process in Europe, rather than as an elective extra. SMi Group provides a CPD accredited Masterclass which aims to address the problems encountered during the creation of a PIP, as …

Click here to read full Press Release

Preparing the Development Safety Update Report

June 7, 2011 | Author: | Posted in Pharmeceuticals

The CIOMS VII Working Group is proposing an internationally harmonised document, the Development Safety Update Report (DSUR) to streamline the process by which drug trial safety is monitored, which should improve patient safety, especially during a time when the effectiveness of a treatment is uncertain. The reason behind this is due to the fact that …

Click here to read full Press Release

Preparing the Development Safety Update Report

June 7, 2011 | Author: | Posted in Pharmeceuticals

The CIOMS VII Working Group is proposing an internationally harmonised document, the Development Safety Update Report (DSUR) to streamline the process by which drug trial safety is monitored, which should improve patient safety, especially during a time when the effectiveness of a treatment is uncertain. The reason behind this is due to the fact that …

Click here to read full Press Release

Social Media: Our Past Present and the Future of Digital Health Online

June 7, 2011 | Author: | Posted in Pharmeceuticals

SMi Group’s CPD accredited Social Media: Our Past, Present and the Future of Digital Health Online masterclass provides industry professionals with the tools needed to plan, execute and fully incorporate social media as part of your pharmaceutical firm’s effective overall online digital strategy.   Social media’s potential as a tool to raise awareness in healthcare …

Click here to read full Press Release

New Pharmaceutical Marketing and Strategy in Opinion Leadership

June 7, 2011 | Author: | Posted in Pharmeceuticals

Massive changes have occurred over the last decade in the pharmaceutical industry and have consequently led to a period of transition, which has necessitated a change in approach. The previous blockbuster model was showing cracks, and reps were no longer seen as the solution to a lot of problems. SMi’s CPD accredited Masterclass gives industry …

Click here to read full Press Release

Intellectual Property and Licensing in Biotech

June 7, 2011 | Author: | Posted in Pharmeceuticals

For biotech ideas to be successful, the idea must be protected by an IP strategy that supports financing and partnering and that results in an IP portfolio that provides sufficient exclusivity to ensure a good return on investment. SMi Group provides a CPD accredited masterclass which helps delegates and their firms ensure IP success by …

Click here to read full Press Release

Patent Issues in the Development of Biosimilar Medicines

June 7, 2011 | Author: | Posted in Pharmeceuticals

Biosimilar medicines are already a commercial reality in the European Union.  The U.S. Healthcare Reform legislation – with its defined pathway for the regulatory approval of follow-on biologics – should open up the U.S. market in the future, but in the meantime, the next batch of biosimilars will face other difficulties in reaching the market, …

Click here to read full Press Release

CONTEXTWEB Study Finds Pharma Advertisers Can Realize Large Gains in Campaign Performance, Efficiency by Targeting Beyond Health Content

June 1, 2011 | Author: | Posted in Pharmeceuticals

NEW YORK, N.Y., June 1, 2011 – A new Intelligence Report released today by CONTEXTWEB Inc., http://www.contextweb.com, a leading provider of integrated digital media services, reports that pharmaceutical advertisers can realize significant gains in campaign effectiveness and efficiency at scale by moving beyond a limited focus on premium health content. The report from CONTEXTWEB, entitled …

Click here to read full Press Release

Elder Pharma Posts Higher Net Profit Of Rs. 15.83 Cr For Q3 Ended Dec-10 – Up By 3%

February 9, 2011 | Author: | Posted in Pharmeceuticals

* Company gets accreditation from Ministry of Health, Japan for its Patalganga plant. * Launches Shelcal K. Mumbai, India, February 09, 2011 — Elder Pharmaceuticals Ltd (NSE- ELDERPHARM) an integrated pharmaceuticals company headquartered in Mumbai has posted excellent results for the third quarter ended Dec 2010 (Q3 FY2011). As per the consolidated unaudited provisional results …

Click here to read full Press Release

Immunologix Teams with GenScript to Produce Human Antibody Therapeutics Ready for Clinical Trials

November 9, 2010 | Author: | Posted in Pharmeceuticals

CHARLESTON, SC and PISCATAWAY, NJ – November 08, 2010 – Immunologix, Inc, a Charleston, SC biotechnology company and a leader in fully human therapeutic antibodies for a variety of diseases and GenScript, a contract research organization (CRO) based in Piscataway, NJ and the industry leader in bio-reagent services, assay development & screening, lead optimization, and …

Click here to read full Press Release

GenScript Launches CloneReadyTM Gene Collections

September 9, 2010 | Author: | Posted in Pharmeceuticals

PISCATAWAY, N.J., Aug 23, 2010- Internationally recognized biology contract research organization GenScript USA Inc. has launched CloneReadyTM Gene Collections for researchers to quickly and cost-effectively get genes they need. GenScript’s CloneReadyTM Gene Collections host hundreds of thousands of popular genes from mammalian and other species. In particular, many full-length cDNA clones are included in the …

Click here to read full Press Release
Tags:

Lactose Intolerance Symptoms Moderate to Severe for Majority of Sufferers

August 5, 2010 | Author: | Posted in Pharmeceuticals

Los Angeles, CA (Your-Story.org) August 5, 2010 – In four separate market surveys conducted by Ritter Pharmaceuticals and Engage Health, Inc., 90% of lactose intolerant individuals reported moderate to severe symptoms of lactose intolerance. For those who suffer from lactose intolerance, the symptoms can be painful and have a significant impact on one’s lifestyle, even …

Click here to read full Press Release

Elder Pharmaceuticals Bags “India’s Most Watched Company Of The Year 2010 Award at the 3rd Annual Pharmaceutical Leadership Summit 2010″

July 8, 2010 | Author: | Posted in Pharmeceuticals

The Rs 720 crore Elder Pharmaceuticals Ltd has received the “India’s Most Watched Company of the Year 2010. Award at the “3rd Annual Pharmaceutical Leadership Summit 2010″. Mumbai, India, July 05, 2010 – The Rs 720 crore Elder Pharmaceuticals Ltd has received the “India’s Most Watched Company of the Year 2010. Award at the “3rd …

Click here to read full Press Release

Trianz Solutions exhibits AcceliantTM 6.0 at DIA Annual Meeting 2010

July 1, 2010 | Author: | Posted in Pharmeceuticals

June 29th 2010, Herndon, Virginia – Trianz Solutions, participated in the 46th Drug Information Association (DIA) Annual Meeting 2010 at Washington, D.C from June 13-17, 2010. Trianz Solutions exhibited AcceliantTM 6.0 at Booth #1146, for Pharmaceutical, Medical Device and Related Products. AcceliantTM is a comprehensive, web-based, end-to-end solution with the unique ability to integrate electronic …

Click here to read full Press Release

Consumers Report Positive Results in Reducing Symptoms of Lactose Intolerance With Lactagen

July 1, 2010 | Author: | Posted in Pharmeceuticals

Los Angeles, CA (Your-Story.org) July 1, 2010 – Consumers report strong acceptance – as high as 95% – of a program designed to help relieve the symptoms of lactose intolerance. According to customers’ product experience reports, the Lactagen® program, developed by Ritter Pharmaceuticals, helped to reduce the digestive discomfort that can be a symptom of …

Click here to read full Press Release

Elder Pharmaceuticals Forays Into the Rs 720 Crore Nicotine Replacement Therapy (NRT) Segment

June 10, 2010 | Author: | Posted in Pharmeceuticals

Ties up with Gelnova Laboratories of Navi Mumbai, pioneers in NGDS (Novel Gel Delivery System) for launch of NRT products in Pastille form. Mumbai, India, June 09, 2010 – Setting its sights onto the Rs 720 crore market for smoking cessation products or nicotine replacement therapy (NRT) products, the Rs 700 cr Elder Pharmaceuticals Ltd …

Click here to read full Press Release

Colgate announces the Colgate Scholarship offer

May 14, 2010 | Author: | Posted in Pharmeceuticals

Learn the 5 basic oral care tips and get an opportunity to earn a scholarship worth Rs.10,000 Colgate-Palmolive (India) Limited, the market leader in oral care, today announced the commencement of the Colgate Scholarship offer. Launched with an aim to reach out to consumers, not only to educate them about basic oral care habits but …

Click here to read full Press Release

The Claremont Hospital Invests 6 Million Pounds to Expand Services Available

April 26, 2010 | Author: | Posted in Pharmeceuticals

The Claremont Hospital has introduced three new private medical care treatments following a 6 million pound investment programme. Sheffield, United Kingdom, 22nd April 2010 – The Claremont Hospital, a private medical care establishment in Sheffield, has recently introduced three new Primary Care Services following a six million pound investment program. The Claremont Hospital is now …

Click here to read full Press Release

Pharmacy OneSource Announces Free Webinar on Hazardous Drug Disposal

April 22, 2010 | Author: | Posted in Pharmeceuticals

Eric S. Kastango and Charlotte Smith address handling of hazardous drugs and proper disposal techniques Bellevue, WA – Pharmacy OneSource, software-as-a-service provider creator of the Simplifi 797 quality assurance web application, is pleased to announce a complimentary webinar presented by industry expert Eric S. Kastango, MBA, RPh, FASHP, and Charlotte A. Smith, R. Ph., M.S., …

Click here to read full Press Release

Expanded International Clinical Trial Services: Clinical Neurology Services (CNS) Worldwide

April 20, 2010 | Author: | Posted in Pharmeceuticals

Rochester, NY and Princeton, NJ:  Date March 30, 2010 Two well established CRO’s, Research Dynamics and Diverse Lynx, have formalized their working relationship as a global strategic alliance for CNS clinical trials. The alliance will benefit both companies’ clients as it will provide expanded service offerings not only in USA but globally. The alliance will …

Click here to read full Press Release

Crossbeta Biosciences completes financing round and appoints Guus Scheefhals as CEO

April 14, 2010 | Author: | Posted in Pharmeceuticals

Today, Crossbeta Biosciences announced that it has successfully completed a financing round of up to Eur 2 million, which is funded by new as well as existing shareholders and also includes an Innovation Grant from SenterNovem. The financing will be used to further advance Crossbeta’s technology in several therapeutic areas and to establish a stronger …

Click here to read full Press Release

ScripNet Selects ReCept Pharmacy as its Preferred Compounding Provider

March 16, 2010 | Author: | Posted in Pharmeceuticals

Compounding allows physicians to tailor dosage strengths, combine or flavor medications for increased compliance, and prevent allergic reactions at a lower cost. Las Vegas, NV – March 16, 2010     ScripNet, a nationwide pharmacy benefits manager (PBM) that contracts with workers’ compensation insurance carriers and pharmacies, is pleased to announce the selection of ReCept Pharmacy as …

Click here to read full Press Release

Other Subcategories of the "Medical & Pharmaceuticals" Category: